Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
- 23 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (16) , 1943-1948
Abstract
Background — DNA variants appearing to predispose to drug-associated “acquired” long-QT syndrome (aLQTS) have been reported in congenital long-QT disease genes. However, the incidence of these genetic risk factors has not been systematically evaluated in a large set of patients with aLQTS. We have previously identified functionally important DNA variants in genes encoding K + channel ancillary subunits in 11% of an aLQTS cohort. Methods and Results — The coding regions of the genes encoding the pore-forming channel proteins KvLQT1, HERG, and SCN5A were screened in (1) the same aLQTS cohort (n=92) and (2) controls, drawn from patients tolerating QT-prolonging drugs (n=67) and cross sections of the Middle Tennessee (n=71) and US populations (n=90). The frequency of three common nonsynonymous coding region polymorphisms was no different between aLQTS and control subjects, as follows: 24% versus 19% for H558R (SCN5A), 3% versus 3% for R34C (SCN5A), and 14% versus 14% for K897T (HERG). Missense mutations (absent in controls) were identified in 5 of 92 patients. KvLQT1 and HERG mutations (one each) reduced K + currents in vitro, consistent with the idea that they augment risk for aLQTS. However, three SCN5A variants did not alter I Na , which argues that they played no role in the aLQTS phenotype. Conclusions — DNA variants in the coding regions of congenital long-QT disease genes predisposing to aLQTS can be identified in ≈10% to 15% of affected subjects, predominantly in genes encoding ancillary subunits.Keywords
This publication has 26 references indexed in Scilit:
- Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese populationJournal of Human Genetics, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac ArrhythmiaCell, 1999
- Genetic and molecular basis of cardiac arrhythmias Impact on clinical managementEuropean Heart Journal, 1999
- Genomic Structure of Three Long QT Syndrome Genes:KVLQT1, HERG,andKCNE1Genomics, 1998
- Molecular Basis of the Long-QT Syndrome Associated with DeafnessNew England Journal of Medicine, 1997
- A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndromeNature Genetics, 1997
- Torsade de Pointes with an antihistamine metabolite: Potassium channel blockade with desmethylastemizoleJACC, 1996
- Genomic Organization of the HumanSCN5AGene Encoding the Cardiac Sodium ChannelGenomics, 1996
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992